Providing the most up-to-date, complete and innovative injectable drug compatibility and stability information in hospital pharmacy worldwide, the King Guide is a proven, authoritative resource for pharmacists, nurses, physicians and other practitioners involved in the preparation and administration of intravenous drugs.
"This is the most updated information on parenteral admixtures on the market."
IJPC Vol.5 No.4 July/August 2001.
Features
We included new stability information to the monographs for: CEFTOBIPROLE MEDOCARIL SODIUM, CEFTAZIDIME, CEFTAZIDIME AND AVIBACTAM SODIUM, ERTAPENEM, MEROPENEM, NALBUPHINE HYDROCHLORIDE, and ORPHENADRINE CITRATE.
Compatibility information was added to the monographs for ACYCLOVIR SODIUM, AMIKACIN SULFATE, AMOXICILLIN SODIUM, AMPHOTERICIN B, CEFOTAXIME SODIUM, CEFTRIAXONE SODIUM, CLONAZEPAM, DIAZEPAM, DOBUTAMINE HYDROCHLORIDE, DOPAMINE HYDROCHLORIDE, FUROSEMIDE, KETAMINE HYDROCHLORIDE, KETOPROFEN, KETOROLAC, METHADONE HYDROCHLORIDE, MIDAZOLAM HYDROCHLORIDE, MORPHINE HYDROCHLORIDE, NALBUPHINE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, PANTOPRAZOLE SODIUM, SODIUM BICARBONATE, TRAMADOL HYDROCHLORIDE, and VANCOMYCIN HYDROCHLORIDE.